Friday, July 10, 2026

pharma · 2019-nCoV

Jieming QU

Jieming QU clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
1
Patents
0
Intelligence · Clinical Programs

Jieming QU projects

1 ClinicalTrials.gov programs sponsored by Jieming QU.

Jieming QU has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Arbidol

    Jieming QU

    2019-nCoV

    approved small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Jieming QU have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.